Anavex Life Sciences Corp (AVXL)

[georgejjl]

Anavex Life Sciences nabs patent win for Alzheimer's candidate
Aug. 31, 2021 10:22 AM ETAnavex Life Sciences Corp. (AVXL)By: Dulan Lokuwithana

Anavex Life Sciences (AVXL +5.2%) is trading higher on below-average volume after the website for the United States Patent and Trademark Office (USPTO) indicated a patent granted for the company covering its lead candidate ANAVEX2-73 for Alzheimer’s disease.

ANAVEX2-73 is an oral small molecule, undergoing studies for multiple indications, including Alzheimer’s disease and Parkinson’s disease.

In July, Anavex (NASDAQ:AVXL) reported promising pre-clinical data for ANAVEX 2-73 to indicate a dose-dependent effect in preventing cognitive impairments in mice.

By H2 2022, the company intends to provide top-line data from a Phase 2b/3 clinical trial for ANAVEX 2-73 in patients with Alzheimer’s disease.

In mid-August, Anavex (AVXL) had enrolled 509 patients in the randomized, double-blind, placebo-controlled study.

Read Next: Anavex Life reports preclinical data for ANAVEX2-73 in Fragile X Syndrome

https://seekingalpha.com/news/3735688-anavex-life-sciences-nabs-patent-win-for-alzheimers-candidate

Good luck and GOD bless,